欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IS/H/0533/002
药品名称Bosutinib TEVA
活性成分
    • Bosutinib dihydrate 400.0 mg
剂型Film-coated tablet
上市许可持有人Teva GmbH Graf-Arco-Str. 3 89079 Ulm Germany Germany
参考成员国 - 产品名称Iceland (IS)
Bosutinib TEVA
互认成员国 - 产品名称
    • Sweden (SE)
    • Norway (NO)
    • Czechia (CZ)
      Bosutinib Teva
    • Germany (DE)
      Bosutinib-ratiopharm 400 mg Filmtabletten
    • Romania (RO)
    • Denmark (DK)
      Bosutinib "Teva"
    • Croatia (HR)
    • Belgium (BE)
      Bosutinib Teva 400 mg filmomhulde tabletten
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
许可日期2024/08/12
最近更新日期2024/11/20
药物ATC编码
    • L01EA04 bosutinib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase